May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Detection of Chemokine Receptor CCR5 on Conjunctival Epithelial Cells in Keratocojunctivitis Sicca
Author Affiliations & Notes
  • A. Sood
    Ophthalmology, Schepens Eye Research Institute. Harvard, Boston, MA, United States
  • P. Argueso
    Ophthalmology, Schepens Eye Research Institute. Harvard, Boston, MA, United States
  • S. Michaud
    Ophthalmology, Schepens Eye Research Institute. Harvard, Boston, MA, United States
  • A. Tisdale
    Ophthalmology, Schepens Eye Research Institute. Harvard, Boston, MA, United States
  • I.K. Gipson
    Ophthalmology, Schepens Eye Research Institute. Harvard, Boston, MA, United States
  • R. Dana
    Ophthalmology, Schepens Eye Research Institute. Harvard, Boston, MA, United States
  • Footnotes
    Commercial Relationships  A. Sood, None; P. Argueso, None; S. Michaud, None; A. Tisdale, None; I.K. Gipson, None; R. Dana, Allergan,Inc. C, R.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 671. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. Sood, P. Argueso, S. Michaud, A. Tisdale, I.K. Gipson, R. Dana; Detection of Chemokine Receptor CCR5 on Conjunctival Epithelial Cells in Keratocojunctivitis Sicca . Invest. Ophthalmol. Vis. Sci. 2003;44(13):671.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Immune-based inflammation as evidenced by upregulation of HLA-DR, CD40 and its ligand (CD40L), and adhesion molecules (ICAM-1) on resident ocular surface epithelial cells has been demonstrated in keratoconjunctivitis sicca (KCS) or dry eye syndrome. Chemokines are chemotactic cytokines, which, along with adhesion molecules, regulate immunoinflammatory responses in tissues. The purpose of the current study is to analyze the cell surface expression of select (CC or beta) chemokine receptors on conjunctival epithelial cells in normal and dry eye patients. Method: Conjunctival impression cytology specimens were collected from normal human subjects (N=10) and dry eye patients (N=20) after a detailed clinical evaluation. The presence of chemokine receptor CCR5 was studied by flow cytometry on cells from impression cytology samples using immunocytological staining techniques. Immunofluorescence of chemokine receptor CCR5 was also studied on cells on cytospin slides obtained from impression cytology specimen and conjuctival biopsies from normal human subjects. Results: Immunofluorescence studies showed positive binding of CCR5 antibody to conjunctival epithelial cells in normal conjunctival biopsies and cytospin slides. By flow cytometry, we found an increased conjunctival cell surface expression of chemokine receptor CCR5 in samples from dry eye patients compared to normals. We also found by flow cytometry that this increased expression of CCR5 in dry eye patients was more so on the resident epithelial cells compared to infiltrating bone marrow derived CD45+ cells. Conclusion: Our finding of increased presence of CCR5 on resident epithelial cells from dry eye patients suggests the potential role for these cells in recruiting T cells or in modulating the immune response given the critical role of CCR5 in mediating T-helper-1 type responses. These data provide a rationale for chemokine receptor blockade as a therapeutic modality in dry eye syndrome.

Keywords: conjunctiva • cornea: tears/tear film/dry eye • inflammation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×